TY  - GEN
AU  - Palamaner Subash Shantha,Ghanshyam
AU  - Mentias,Amgad
AU  - Inampudi,Chakradhari
AU  - Kumar,Anita A
AU  - Chaikriangkrai,Kongkiat
AU  - Bhise,Viraj
AU  - Deshmukh,Abhishek
AU  - Patel,Nileshkumar
AU  - Pancholy,Samir
AU  - Horwitz,Phillip A
AU  - Mickelsen,Steven
AU  - Bhave,Prashant D
AU  - Giudici,Michael
AU  - Oral,Hakan
AU  - Vaughan Sarrazin,Mary S
TI  - Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation
SN  - 2047-9980
PY  - 2018///0611
KW  - Administration, Oral
KW  - Administrative Claims, Healthcare
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - administration & dosage
KW  - Atrial Fibrillation
KW  - diagnosis
KW  - Cause of Death
KW  - Chi-Square Distribution
KW  - Dabigatran
KW  - Databases, Factual
KW  - Female
KW  - Heart Failure
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Medicare
KW  - Multivariate Analysis
KW  - Myocardial Infarction
KW  - Patient Admission
KW  - Propensity Score
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Rivaroxaban
KW  - Sex Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - epidemiology
KW  - Warfarin
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1161/JAHA.117.006381
ER  -